Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation

Name: Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation
Published: 2008
License: Public Domain

Heinrich-Heine University, Duesseldorf · 2008

ClinicalTrials.gov · Datasets · License: Public Domain · 2008

Open Source ↗

acute-myeloid-leukemia

myelodysplastic syndrome, acute myeloid leukemia, myelodysplastic syndrome (mds), acute myeloid leukemia (aml), stem cell transplantation, 5-azacitidine, donor lymphocyte infusion, mds or aml relapsed after stem cell transplantation, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation

Related documents